Calciphylaxis in Hemodialysis Patients: Diagnosis and Treatment about a Case

S. Hamine *

Department of Nephrology and Dialysis, University Hospital Cente Henri Mondor Créteil, France.

N. Jouan

Department of Nephrology and Dialysis, University Hospital Cente Henri Mondor Créteil, France.

D. Dahmane

Department of Nephrology and Dialysis, University Hospital Cente Henri Mondor Créteil, France.

P. Grimbert

Department of Nephrology and Dialysis, University Hospital Cente Henri Mondor Créteil, France.

*Author to whom correspondence should be addressed.


Abstract

Calciphylaxis is a condition that causes cutaneous necrosis, which primarily affects patients with end-stage renal disease undergoing dialysis. Histologically, this condition is characterized by subintimal calcific deposits in small-caliber arteries, leading to luminal obstruction. Unlike medial calcification, which affects the media of arteries, calciphylaxis affects the intima of arterioles. Early diagnosis and appropriate management, including addressing the underlying cause, can improve the poor prognosis associated with this condition.

In this case report, a 59-year-old woman with end-stage diabetic nephropathy and chronic kidney disease on hemodialysis presented with large, painful, ulcerated lesions on the inner aspects of both knees that were shallow and showed no signs of bacterial superinfection. Hypercalcemia was noted on biochemical analysis, and radiographs of the thighs revealed vascular calcifications of the superficial femoral, popliteal, and leg arteries bilaterally. Histological examination revealed dermal neovascularization with stasis thrombi and secondary epidermal necrosis, indicating an underlying thromboembolic phenomenon. The management consisted of analgesic treatment and daily local care, along with intensified dialysis sessions with sodium thiosulfate and rheopheresis. A marked improvement in the patient's condition was observed following an accidental occurrence of resolving gas embolism after hyperbaric oxygen therapy, which played a significant role in the regression of cutaneous necrosis.

Therefore, hyperbaric oxygenation may be considered as a potential treatment option for calciphylaxis.

Keywords: Calciphylaxis, hemodialysis, renal disease, calcific deposits


How to Cite

Hamine , S., Jouan , N., Dahmane , D., & Grimbert , P. (2023). Calciphylaxis in Hemodialysis Patients: Diagnosis and Treatment about a Case. Asian Journal of Research in Nephrology, 6(1), 69–72. Retrieved from https://journalajrn.com/index.php/AJRN/article/view/62


References

Duval A, Moranne O, Vanhille P, Hachulla E, Delaporte E. Artériolopathie calcique (calciphylaxie) calcic arteriolopathy (calciphylaxis). La Revue de Médecine Interne. 2006;27(3):184-195.

Au S, Crawford RI. Three-dimensional analysis of a calciphylaxis plaque: Clues to pathogenesis. J Am Acad Dermatol. 2002;47(1):53-7.

Agharbi FZ, et al. Uremic calciphylaxis: About two cases. Pan African Medical Journal; 2020.

Speer MY, Giachelli CM. Regulation of cardiovascular calcification. Cardiovasc Pathol. 2004;13(2):63-70.

Zabirnyk A, et al. Un nouvel agent anti-cristallisation, inhibe la calcification induite dans un modèle in vitro de calcification de la valve aortique humaine. Vascul Pharmaco; 2019.

Baldwin C, et al. Prise en charge multi-interventionnelle de la calciphylaxie: A propos de 7 cas. Suis J Kidney Dis; 2011.

Ellis CL, et al. Spécificité discutable des résultats histologiques dans l'artériolopathie urémique calcifiante. Rein Int; 2018.

Chen NX, et al. La calcification artérielle induite par les adipocytes est prévenue grâce au thiosulfate de sodium. Biochem Biophys Res Commun; 2014.

Gabel CK, et al. Assessment of outcomes of calciphylaxis J Am Acad Dermatol; 2021.

Cassius C, et al. Calciphylaxis in haemodialysed patients : diagnostic value of calcifications in cutaneous biopsy Br J Dermatol; 2018.

Basile C, et al. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: A case series. J Nephrol; 2002.